BrainAurora Medical Technology Limited (HKG:6681)

Market Cap	1.86B -78.5%
Revenue (ttm)	276.94M +40.7%
Net Income	-372.32M
EPS	-0.30
Shares Out	1.36B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	117,677,590
Open	1.535
Previous Close	1.500
Day's Range	1.350 - 1.535
52-Week Range	0.605 - 8.480
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 27, 2026

About HKG:6681

BrainAurora Medical Technology Limited provides system integral software solutions for hospitals and research projects in Mainland China. The company develops medical-grade digital therapy (DTx) products for cognitive impairment. It offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychiatric disorders, and child development deficiencies. The company develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Bas...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 165
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6681

Financial Performance

In 2025, HKG:6681's revenue was 220.05 million, an increase of 79.91% compared to the previous year's 122.31 million. Losses were -314.86 million, 58.8% more than in 2024.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error